Stocksigma LogoStocksigma Logo

Hester Biosciences Posts Strong Q2 FY27 Results; Approves Loan to Africa Arm

Hester Biosciences reported a 38% YoY increase in consolidated revenue to INR 979.12m for Q2 FY27 ended 30th Sep'26, with PAT rising 44% YoY to INR

Hester Biosciences Posts Strong Q2 FY27 Results; Approves Loan to Africa Arm

Hester Biosciences Ltd 路 Others (Uncategorized) 路 05 Nov 2026, 4:57 pm

Hester Biosciences Posts Strong Q2 FY27 Results; Approves Loan to Africa Arm Hester Biosciences reported a 38% YoY increase in consolidated revenue to INR 979.12m for Q2 FY27 ended 30th Sep'26, with PAT rising 44% YoY to INR 206.31m. Consolidated EBITDA grew 55% YoY to INR 365.16m, delivering a 37% margin. Standalone PAT jumped 131% YoY to INR 166.60m. H1 FY27 consolidated PAT reached INR 1,173.63m, aided by an exceptional gain of INR 857.68m from loan restructuring with the Gates Foundation. The board also approved an unsecured loan of USD 1m at 9% p.a. to wholly-owned subsidiary Hester Africa.

Original exchange filing (PDF)

More announcements from Hester Biosciences Ltd

All Hester Biosciences Ltd announcements